Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,238.00
Bid: 1,238.00
Ask: 1,238.20
Change: 13.80 (1.13%)
Spread: 0.20 (0.02%)
Open: 1,212.40
High: 1,240.20
Low: 1,210.80
Yest. Close: 1,224.20
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

GSK outlook brightens as Brexit brings currency windfall

By Ben Hirschler LONDON, July 27 (Reuters) - Demand for new medicines helped GlaxoSmithKline grow earnings in the second quarter and the drugmaker is set for big gains in the rest of 2016 thanks to a weak pound, after Britain's vote to leave the European Union. GSK, whose outgoing chi

27 Jul 16 11:16

GSK chases next biotech asthma drug with $230 mln J&J deal

By Ben Hirschler LONDON, July 27 (Reuters) - GlaxoSmithKline has bought global rights to an experimental drug from Johnson & Johnson for up to 175 million pounds ($230 million), raising its bet on a new generation of biotech medicines for severe asthma. The British drugmaker recently

27 Jul 16 11:00

GlaxoSmithKline to invest GBP275m in UK manufacturing sites

(ShareCast News) - Amid growing concerns about how Brexit might affect investment in the UK, pharmaceuticals giant GlaxoSmithKline has announced plans to spend £275m on three of its UK manufacturing sites to boost production and support delivery of its latest respiratory and large molecule biologica

27 Jul 16 10:06

UPDATE 3-GlaxoSmithKline invests $360 mln in UK despite Brexit vote

* Drugmaker had opposed Brexit on fears over drug regulation * Government says decision a clear vote of confidence in UK * Investment at sites making respiratory and biotech drugs * UK accounts for nearly half GSK R&D, third manufacturing (Adds proportion of GSK manufacturing

27 Jul 16 08:20

UPDATE 2-GlaxoSmithKline invests $360 mln in UK despite Brexit vote

* Drugmaker had opposed Brexit on fears over drug regulation * Government says decision a clear vote of confidence in UK * Investment at sites making respiratory and biotech drugs (Adds government reaction, more on other post-Brexit investments) By Ben Hirschler LONDON,

27 Jul 16 07:07

UPDATE 1-GlaxoSmithKline invests $360 mln in post-Brexit UK manufacturing

(Adds CEO comment, tax incentives, further details) By Ben Hirschler LONDON, July 27 (Reuters) - GlaxoSmithKline plans 275 million pounds ($361 million) of new investments at three drug manufacturing sites in Britain, signalling its confidence in the country despite last month's vote

27 Jul 16 06:28

GlaxoSmithKline invests $360 mln in post-Brexit UK manufacturing

LONDON, July 27 (Reuters) - GlaxoSmithKline plans 275 million pounds ($361 million) of new investments at three drug manufacturing sites in Britain, signalling its confidence in the country despite last month's vote to leave the European Union. (Reporting by Ben Hirschler; Editing by David Holm

27 Jul 16 06:03

Germany plans to extend price brake for drugs under statutory insurance

BERLIN, July 25 (Reuters) - Germany wants to extend a price brake for drugs covered by statutory health insurance for five years beyond 2017, stretching out the measure introduced in 2009, a draft law seen by Reuters shows. The health ministry estimates savings from the extension will amoun

25 Jul 16 15:09

Malaria drug may help in cancer fight, early research finds

LONDON, July 25 (Reuters) - An off-patent malaria drug could help to destroy cancer cells by making them more susceptible to radiotherapy, according to early work that has prompted British scientists to start a clinical trial. Researchers reported on Monday that atovaquone boosted oxygen le

25 Jul 16 09:00

UK Earnings, Trading Statements Calendar - Next 7 Days

20 Jul 16 15:06

Your inhaler's watching you: drugmakers race for smart devices

* Digitally connected devices aim to track medicine use * GSK, AstraZeneca, Novartis all working on smart inhalers * Innovation drive comes as sector faces growing competition By Ben Hirschler LONDON, July 20 (Reuters) - Makers of inhalers to treat asthma and chronic lung

20 Jul 16 12:42

Novartis in no rush to sell down stake on GSK consumer venture

July 19 (Reuters) - Novartis is happy with the performance of its consumer health joint venture with GlaxoSmithKline, in which the Swiss drugmaker has a minority stake, and is in no rush to exit the collaboration early, its chief executive said. There has been speculation that Novartis migh

19 Jul 16 13:20

Apple teams up with GlaxoSmithKline for ResearchKit project

(ShareCast News) - Apple has stepped up its foray into the health technology world, teaming up with British firm GlaxoSmithKline for a project using ResearchKit, a medical platform for studies and clinical trials. The two companies will gather data from patients using an iOS app powered by ResearchK

19 Jul 16 08:40

Capita bumps up forecast for 2016 dividends, mid-caps to take Brexit hit

(ShareCast News) - The fall in sterling following Brexit would deliver an immediate boost to the value of companies' dividend payments but potential recessionary pressures would hit profits and dividends from UK-focused mid-caps hardest, Capita said in its second quarter 2016 Dividend Monitor. De

18 Jul 16 12:28

Glaxo's ViiV Sees Positive Results In Phase IIIb Triumeq Study

18 Jul 16 10:39

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.